ChenZ., and John WherryE. (2020). T cell responses in patients with COVID-19. Nat Rev Immunol, 20, 529–536.
2.
DasK.M., LeeE.Y., SinghR., EnaniM.A., DossariK.L., GorkomK.V., et al. (2017). Follow-up chest radiographic findings in patients with MERS-CoV after recovery. Indian J Radiol Imaging, 27, 342–349.
3.
HuB., GuoH., ZhouP. and ShiZ.L. (2021). Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol, 19, 141–154.
4.
HuangC., WangY., LiX., RenL., ZhaoJ., HuY., et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395, 497–506.
5.
LiuY., YangY., ZhangC., HuangF., WangF., YuanJ., et al. (2020). Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci, 63, 364–374.
6.
NadimM.K., ForniL.G., MehtaR.L., ConnorM.J.Jr., LiuK.D., OstermannM., et al. (2020). COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol, 16, 747–764.
7.
PanY., GuanH., ZhouS., WangY., LiQ., ZhuT., et al. (2020). Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Euro Radiol, 30, 3306–3309.
8.
PatraT., MeyerK., GeerlingL., IsbellT.S., HoftD.F., BrienJ., et al. (2020). SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells. PLoS Pathog 16,e1009128.
9.
SalamaC., HanJ., YauL., ReissW.G., KramerB., NeidhartJ.D., et al. (2021). Tocilizumab in patients hospitalized with COVID-19 pneumonia. N Engl J Med, 384, 20–30.
10.
SchellerJ., ChalarisA., Schmidt-ArrasD., and Rose-JohnS. (2011). The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochem Biophys Acta, 1813, 878–888.
11.
TseG.M.K., ToK.F., ChanP.K.S., LoA.W.I., NgK.C., WuA., et al. (2004) Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS). J Clin Pathol, 57, 260–265.
12.
WangS., MaP., ZhangS., SongS., WangZ., MaY., et al. (2020). Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-center retrospective study. Diabetologia, 63, 2102–2111.
